Central Garden & Pet - CENT Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Central Garden & Pet in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CENT shares.
View CENT analyst ratings or view top-rated stocks.

1 analysts have issued twelve-month price objectives for Central Garden & Pet's shares. Their CENT share price forecasts range from $50.00 to $60.00. On average, they predict the company's share price to reach $55.00 in the next year. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for CENT or view top-rated stocks among Wall Street analysts.

Central Garden & Pet's stock was trading at $37.45 at the beginning of the year. Since then, CENT stock has increased by 14.3% and is now trading at $42.79.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our CENT earnings forecast.

Central Garden & Pet (NASDAQ:CENT) released its quarterly earnings data on Monday, November, 21st. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.07. The firm earned $707.44 million during the quarter, compared to the consensus estimate of $724.45 million. Central Garden & Pet had a net margin of 4.08% and a trailing twelve-month return on equity of 10.15%.

Central Garden & Pet updated its FY 2023 earnings guidance on Thursday, December, 22nd. The company provided EPS guidance of $2.60-$2.80 for the period, compared to the consensus earnings per share estimate of $2.93. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Central Garden & Pet investors own include Skechers U.S.A. (SKX), General Electric (GE), Scotts Miracle-Gro (SMG), Zoetis (ZTS), Bunge (BG), Brinker International (EAT), Kroger (KR), Pfizer (PFE), Domtar (UFS) and Verizon Communications (VZ).

Central Garden & Pet trades on the NASDAQ under the ticker symbol "CENT."

Central Garden & Pet's stock is owned by many different institutional and retail investors. Top institutional shareholders include Tokio Marine Asset Management Co. Ltd. (0.06%), Bfsg LLC (0.06%), Assenagon Asset Management S.A. (0.06%), North Star Investment Management Corp. (0.04%), Yousif Capital Management LLC (0.01%) and Comerica Bank (0.01%). Insiders that own company stock include Brooks Pennington III, Daniel P Myers, George A Yuhas, Howard Machek, John D Walker III, John D Walker III, John Edward Hanson, John Ranelli, Nicholas Lahanas and Thomas J Colligan.
View institutional ownership trends.

Shares of CENT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CENT stock can currently be purchased for approximately $42.79.

Central Garden & Pet (NASDAQ:CENT) has a market capitalization of $2.32 billion and generates $3.34 billion in revenue each year. The company earns $152.15 million in net income (profit) each year or $2.46 on an earnings per share basis.

The company employs 7,000 workers across the globe.

Central Garden & Pet's mailing address is 1340 TREAT BOULEVARD SUITE 600, WALNUT CREEK CA, 94597. The official website for the company is www.central.com. The company can be reached via phone at (925) 948-4000, via email at fedelmann@central.com, or via fax at 302-636-5454.